NovaBay Pharmaceuticals, Inc.

NYSEAM:NBY Voorraadrapport

Marktkapitalisatie: US$3.7m

NovaBay Pharmaceuticals Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

NovaBay Pharmaceuticals has a total shareholder equity of $-617.0K and total debt of $696.0K, which brings its debt-to-equity ratio to -112.8%. Its total assets and total liabilities are $3.9M and $4.5M respectively.

Belangrijke informatie

-112.8%

Verhouding schuld/eigen vermogen

US$696.00k

Schuld

Rente dekkingsration/a
ContantUS$751.00k
Aandelen-US$617.00k
Totaal verplichtingenUS$4.54m
Totaal activaUS$3.93m

Recente financiële gezondheidsupdates

We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Mar 29
We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Recent updates

We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Mar 29
We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Analyse van de financiële positie

Kortlopende schulden: NBY has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Langlopende schulden: NBY has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: NBY has negative shareholder equity, which is a more serious situation than a high debt level.

Schuld verminderen: NBY's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: NBY has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.

Voorspelling contante baan: NBY is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.


Ontdek gezonde bedrijven